Case Note & Summary
The case involved two appeals concerning the validity of the respondent's claim to the trade mark 'Navaratna Pharmaceutical Laboratories'. The respondent, a firm manufacturing medicinal products, had been using the trade mark since 1926 and had registered it under the Trade Marks Act, 1940. The appellant, who also manufactured medicinal products, sought to register 'Navaratna Kalpa' as a trade mark, leading to opposition from the respondent. The District Court ruled in favor of the respondent, confirming the validity of its trade mark and granting an injunction against the appellant. The High Court upheld this decision, leading to the present appeals. The core legal issues revolved around the distinctiveness of the trade mark and whether the appellant's mark infringed upon the respondent's rights. The court analyzed the requirements for registration under Section 6 of the Trade Marks Act, particularly the concept of acquired distinctiveness for marks in use prior to February 25, 1937. The Supreme Court affirmed the lower courts' findings, emphasizing that a mark could qualify for registration despite not being inherently distinctive if it had acquired distinctiveness through long use. The court also ruled that the appellant's mark was deceptively similar to the respondent's, thus affirming the injunction against the appellant. The decision underscored the importance of protecting established trade marks in the pharmaceutical industry.
Headnote
A) Trade Marks - Registration of Trade Marks - Acquired Distinctiveness - Trade Marks Act, 1940, Section 6(3) - A mark not adapted to distinguish may still qualify for registration if it has acquired distinctiveness through long use prior to February 25, 1937. The court held that the respondent's mark had been used for a long time and had become associated exclusively with its goods, thus justifying its registration (Paras 737-752). B) Trade Marks - Infringement - Deceptively Similar Marks - Trade Marks Act, 1940, Section 21 - The onus is on the plaintiff to prove that the defendant's mark is deceptively similar. The court found that the appellant's mark was indeed deceptively similar to the respondent's mark, thus affirming the lower courts' decisions (Paras 754-756).
Issue of Consideration
Whether the trade mark 'Navaratna Pharmaceutical Laboratories' was validly registered and whether the appellant's use of 'Navaratna Kalpa' constituted infringement.
Final Decision
The Supreme Court upheld the registration of the trade mark 'Navaratna Pharmaceutical Laboratories' based on acquired distinctiveness and affirmed the lower courts' findings regarding the deceptive similarity of the appellant's mark.
Law Points
- Trade Marks Act
- 1940
- Section 6
- Section 21
- passing off
- infringement of trade mark
- acquired distinctiveness
